GenSpera, Inc. (OTC MKTS: GNSZ) conceives, designs and develops curative cancer therapies that are core to the principles of extending human life. The company’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. The company’s leading drug candidate, Mipsagargin, is expected to have potential efficacy in a wide variety of tumor types. For more information, visit the company’s website at www.genspera.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.